A mathematical model separates quantitatively the cytostatic and cytotoxic effects of a HER2 tyrosine kinase inhibitor
2007
Mathematical Model of Lapatinib's Effects on HER2-Overexpressing Cells
publication
Evidence: moderate
Author Information
Author(s): Peter Hinow, Shizhen Wang, Carlos L. Arteaga, Glenn F. Webb
Primary Institution: Vanderbilt University
Hypothesis
Does lapatinib selectively block cell cycle progression in HER2-overexpressing cells?
Conclusion
The model quantitatively separates the cytostatic and cytotoxic effects of lapatinib, suggesting implications for cancer treatment.
Supporting Evidence
- Lapatinib slows the transition through the G1 phase of the cell cycle.
- The model indicates a late cytotoxic effect of lapatinib after prolonged exposure.
- Both cytostatic and cytotoxic effects depend on the dosage of lapatinib.
Takeaway
This study uses math to show how a cancer drug works by slowing down the growth of certain cells and eventually killing them.
Methodology
The study used human mammary epithelial cells overexpressing HER2 and a mathematical model to analyze the effects of lapatinib on cell growth.
Limitations
The study's in vitro findings may not directly translate to in vivo situations.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website